Ginkgo Bioworks Holdings (DNA) Exchange Rate Effect (2021 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Exchange Rate Effect of -$129000.0 for Q1 2026, up 15.13% on a QoQ basis from -$152000.0 in Q4 2025, and down 274.32% year-over-year from $74000.0 in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at -$129000.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 274.32% year-over-year to -$129000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2000.0 (up 96.0% YoY) and the FY2025 annual result came in at $201000.0, up 171.53% from the prior year.
- Exchange Rate Effect was -$129000.0 for Q1 2026 at Ginkgo Bioworks Holdings, up from -$152000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.1 million in Q4 2022 and bottomed at -$469000.0 in Q2 2023.
- A 5-year average of $6529.4 and a median of -$35000.0 in 2024 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect surged 10090.91% — and 2024, when it slumped 503.85%.
- Ginkgo Bioworks Holdings' Exchange Rate Effect stood at $1.1 million in 2022, then tumbled by 90.72% to $102000.0 in 2023, then slumped by 171.57% to -$73000.0 in 2024, then tumbled by 108.22% to -$152000.0 in 2025, then climbed by 15.13% to -$129000.0 in 2026.
- Business Quant data shows DNA's Exchange Rate Effect at -$129000.0 in Q1 2026, -$152000.0 in Q4 2025, and $93000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | -129,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129,000.00 |
| Mar 31, 2026 | -129,000.00 |
| Dec 31, 2025 | -152,000.00 |
| Dec 31, 2025 | -152,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | -73,000.00 |
| Dec 31, 2024 | -73,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Mar 31, 2024 | -157,000.00 |
| Mar 31, 2024 | -157,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Dec 31, 2023 | 102,000.00 |